6 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Jul 23
Current report (foreign)
6:18am
to reduce, reuse and recycle waste. In fiscal year 2022, we diverted more than 80% of our waste from landfill. For example, we implemented AI technology
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 Jun 21
Current report (foreign)
7:38am
be challenging – which is why Takeda Belgium’s pioneering project to recycle wastewater at our Lessines manufacturing site is so remarkable. We’ve
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
17 Dec 20
Current report (foreign)
6:01am
, energy-efficient, water- cooled air compressors resulting in 156,000 kWh savings annually. The new air compressors will also recycle heat
20FR12B/A
TAK
Takeda Pharmaceutical Co
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
males that interferes with the body’s ability to break down and recycle waste substances. ELAPRASE was approved by the FDA in July 2006 and granted
20FR12B
TAK
Takeda Pharmaceutical Co
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
males that interferes with the body’s ability to break down and recycle waste substances. ELAPRASE was approved by the FDA in July 2006 and granted
DRS/A
fudjde k91pzqcssrnk
16 Nov 18
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next